These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9711830)

  • 1. Novel regio- and stereoselective O-6-desulfation of the glucosamine moiety of heparin with N-methylpyrrolidinone-water or N,N-dimethylformamide-water mixtures.
    Baumann H; Scheen H; Huppertz B; Keller R
    Carbohydr Res; 1998 Jun; 308(3-4):381-8. PubMed ID: 9711830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective N-desulfation of heparin with dimethyl sulfoxide containing water or methanol.
    Inoue Y; Nagasawa K
    Carbohydr Res; 1976 Jan; 46(1):87-95. PubMed ID: 1248016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of anti-factor Xa active, 3-O-sulfated glucosamine-rich sequences by controlled desulfation of oversulfated heparins.
    Naggi A; De Cristofano B; Bisio A; Torri G; Casu B
    Carbohydr Res; 2001 Dec; 336(4):283-90. PubMed ID: 11728396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2.
    Ishihara M; Takano R; Kanda T; Hayashi K; Hara S; Kikuchi H; Yoshida K
    J Biochem; 1995 Dec; 118(6):1255-60. PubMed ID: 8720143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concepts for improved regioselective placement of O-sulfo, N-sulfo, N-acetyl, and N-carboxymethyl groups in chitosan derivatives.
    Baumann H; Faust V
    Carbohydr Res; 2001 Mar; 331(1):43-57. PubMed ID: 11284504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solvolytic desulfation of glycosaminoglycuronan sulfates with dimethyl sulfoxide containing water or methanol.
    Nagasawa K; Inoue Y; Kamata T
    Carbohydr Res; 1977 Sep; 58(1):47-55. PubMed ID: 144018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of ester sulfates in heparin to solvolysis and dilute acid treatment.
    Kosakai M; Yosizawa Z
    J Biochem; 1979 Jul; 86(1):147-53. PubMed ID: 573262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical modification of heparin and heparosan.
    Raman K; Kuberan B; Arungundram S
    Methods Mol Biol; 2015; 1229():31-6. PubMed ID: 25325941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfation of some chemically-modified heparins. Formation of a 3-sulfate analog of heparin.
    Rej RN; Ludwig-Baxter KG; Perlin AS
    Carbohydr Res; 1991 Mar; 210():299-310. PubMed ID: 1878883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of N-sulfated glucosamine to N-sulfated mannosamine in an unsaturated heparin disaccharide by non-enzymatic, base-catalyzed C-2 epimerization during enzymatic oligosaccharide preparation.
    Yamada S; Watanabe M; Sugahara K
    Carbohydr Res; 1998 Jul; 309(3):261-8. PubMed ID: 9742689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desulfation of sulfated galactans with chlorotrimethylsilane. Characterization of beta-carrageenan by 1H NMR spectroscopy.
    Kolender AA; Matulewicz MC
    Carbohydr Res; 2004 Jun; 339(9):1619-29. PubMed ID: 15183736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a heparan sulfate 3-O-sulfation specific peeling reaction.
    Huang Y; Mao Y; Zong C; Lin C; Boons GJ; Zaia J
    Anal Chem; 2015 Jan; 87(1):592-600. PubMed ID: 25486437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the stability of heparin: NMR evidence for the rearrangement of sulfated iduronate in phosphate buffer.
    Kozlowski AM; Yates EA; Roubroeks JP; Tømmeraas K; Larsen FH; Smith AM; Morris GA
    Carbohydr Polym; 2023 May; 308():120649. PubMed ID: 36813341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligosaccharide Chromatographic Techniques for Quantitation of Structural Process-Related Impurities in Heparin Resulting From 2-O Desulfation.
    Anger P; Martinez C; Mourier P; Viskov C
    Front Med (Lausanne); 2018; 5():346. PubMed ID: 30619858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and anti-HIV activity of O-acylated heparin and dermatan sulfate derivatives with low anticoagulant effect.
    Bârzu T; Level M; Petitou M; Lormeau JC; Choay J; Schols D; Baba M; Pauwels R; Witvrouw M; De Clercq E
    J Med Chem; 1993 Nov; 36(23):3546-55. PubMed ID: 8246223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical Approaches to Prepare Modified Heparin and Heparosan Polymers for Biological Studies.
    Raman K; Arungundram S
    Methods Mol Biol; 2022; 2303():289-296. PubMed ID: 34626387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of the binding of heparin to granulocyte colony-stimulating factor: importance of sulfate groups.
    Liang A; Liu X; Du Y; Wang K; Lin B
    Electrophoresis; 2008 Mar; 29(6):1286-90. PubMed ID: 18288776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid-catalyzed and solvolytic desulfation of H2SO4-hydrolyzed cellulose nanocrystals.
    Jiang F; Esker AR; Roman M
    Langmuir; 2010 Dec; 26(23):17919-25. PubMed ID: 21073156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solvolytic desulfation of 2-deoxy-2-sulfoamino-D-glucose and D-glucose 6-sulfate.
    Nagasawa K; Inoue Y
    Carbohydr Res; 1974 Sep; 36(2):265-71. PubMed ID: 4426052
    [No Abstract]   [Full Text] [Related]  

  • 20. Nickel-catalyzed stereoselective glycosylation with C(2)-N-substituted benzylidene D-glucosamine and galactosamine trichloroacetimidates for the formation of 1,2-cis-2-amino glycosides. Applications to the synthesis of heparin disaccharides, GPI anchor pseudodisaccharides, and α-GalNAc.
    Mensah EA; Yu F; Nguyen HM
    J Am Chem Soc; 2010 Oct; 132(40):14288-302. PubMed ID: 20860359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.